Found this...
http://www.prath.eu/project.htm
Is this something new or just a Eculizumab clone?
there is still hope!
Cheers,
Frank
Tags:
Permalink Reply by Cheryl Biermann on November 30, 2011 at 2:14pm It couldn't be a clone because Alexion would have the rights for a certain number of years before generics could be used. This is the first I've seen on this, thanks for the post, we will look into it.
Permalink Reply by Cheryl Biermann on November 30, 2011 at 7:03pm After reading through the paper, I solicited the opinion of trusted medical advisors, this is what one of them said.
"This is interesting. It looks like another antibody created to block
C5, being developed by a group of investigators in Europe. It looks
like in part the research is sponsored by a rare disease network and
has had promising results in animal models of aHUS."
Back to me: It is the first and only thing I've read about this and even after trying to google it, I could come up with nothing else. I did notice it was published last year. Hopefully, the success with Eculizumab does not prohibit other researchers to continue their promising leads!
Permalink Reply by Linda Burke on December 1, 2011 at 1:48am I've just posted a blog that might provide some factual info...http://atypicalhus.ning.com/profiles/blogs/regarding-mubodina
Permalink Reply by Cheryl Biermann on December 1, 2011 at 10:23am Thanks for posting what you've found, we were also assuming that if this project continues it is several years down the road and not something for consideration anytime soon as the process is very long from approval of patents to trials to market. Based on the need for drugs to treat inflamatory diseases, I certainly hope this type of research continues.
Linda Burke se aid:
I've just posted a blog that might provide some factual info...http://atypicalhus.ning.com/profiles/blogs/regarding-mubodina
WELCOME - Friends, Family Members, Patients, and Researchers - JOIN US!
The Foundation for Children with Atypical HUS encourages patients and investigators to share information and explore options/resources as we work together to gain insight into this rare complement disorder. By increasing contact opportunities with researchers and medical personnel interested in helping the aHUS community, our stories foster a better understanding of atypical hemolytic uremic syndrome.
Sharing information, inspiration and support for one another, we seek to gather together people and knowledge as we strive to improve the lives of patients and families dealing with a diagnosis of aHUS.
NEW DIAGNOSIS OF aHUS?
Be proactive! Get the medical basics of aHUS, what lab values to monitor, and areas of concern...check out the "aHUS Bootcamp" and "About aHUS" tabs at the top of this page!
If your doctor has never treated a case of aHUS, please print out our 'Doc to Doc Registry' and ask him/her to contact a physician versed in the complexities of aHUS and new options for 2011 genetic testing and treatment.
************************
NOTE: Our 'Send a Message" function on each Member's page allows for private discussion of personal content. As with any social network, be cautious about giving personal contact information (home email info, phone number) until you have an established relationship with another person, organization, or associated website.
Your tax-deductible purchase of one or more bracelets will directly fund research to help end the tragedy and heartbreak that aHUS families live with every day. Each bracelet has an appraised value of $825, but your purchase price is only $295.

© 2012 Created by ALPHA MARKETING.
Powered by
.